| dc.contributor.author | Bobomuratov T.A ., Karimova N.A., Tursunbaev A.K., Bakirova M.A | |
| dc.date.accessioned | 2023-02-02T10:25:56Z | |
| dc.date.available | 2023-02-02T10:25:56Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/6243 | |
| dc.description.abstract | COVID-19 (from the English Coronavirus disease 2019) is a new epidemic infectious disease characterized by a relatively high contagiousness and the likelihood of developing life-threatening complications in the form of acute respiratory distress syndrome, acute respiratory and multiple organ failure. a retrospective analysis of the incidence, clinical course and treatment of children with COVID-19 who were treated in a specialized hospital for the treatment of patients with coronavirus infection. We conducted a retrospective analysis of the case histories of 86 children of various ages who were hospitalized with a confirmed diagnosis of a new coronavirus infection COVID-19 in September-November 2020. There were 51 (%) boys, 34 (%) girls. Depending on age, patients were divided into 4 groups: up to 1 year - 7 (%), from 1 year to 6 years - 27 (%), from 7 to 12 years - 26 (%) and over 12 years - 26 (% ). Studies have shown that children with mild COVID-19 were treated on an outpatient basis and therefore were not included in the surveyed group. Children with moderate and severe forms of COVID-19 received inpatient treatment, and in our study, patients with moderate course - 57 (66.3%), and a severe course was noted in 29 (33.7%) children. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Texas Journal of Medical Science | en_US |
| dc.subject | COVID-19, children, cardiovascular system, myocardial damage, diagnosis | en_US |
| dc.title | New Coronavirus Infection | en_US |
| dc.type | Article | en_US |